About Us
Opyl is a new generation company that provides leading biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.
Our vision is to improve health and wellness by optimising data assets and digital activation to advance technologies for life.
Utilising our novel digital platforms, artificial intelligence tools, data analysis methodologies, and our health subject matter and market expertise, we provide our clients with actionable solutions and competitive insight into the real lived experience of patients and healthcare providers managing an illness, injury or disorder.
The actionable insights we deliver give our clients clear competitive advantage that can be transformative in helping them to achieve the validation, improvement, advancement and adoption of their innovative technologies and clinical interventions.
We know that patients report more about their health experience to social networks and digital platforms than they do to their doctor.
Our point of difference is the deep healthcare marketing and data science expertise of our diverse team and our understanding of real world data, particularly patient reported outcomes (PRO) and the continuous data and dialogue stream within social media.
Opyl is investing in researching and developing new technologies as well as providing competitive digital marketing and insights services to healthcare, wellness and science technology-focussed clients.
We know that patients report more about their health experience to social networks and digital platforms than they do to their doctor.
Leadership Team
Dr Julian Chick
Chairman
Michelle Gallaher
Chief Executive Officer
Damon Rasheed
Executive Director
Marat Basyrov
Non Executive Director
Mark Ziirsen
Non Executive Director
David Iilja
Company Secretary
